Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Annals of Medicine|November 8, 2023
Molecular classifications of prostate cancer: basis for individualized risk stratification and precision therapyQintao Ge, Jiawei Li, Feixiang Yang, et al.
Journal of Hematology & Oncology|June 18, 2026
Cancer-associated fibroblasts and tertiary lymphoid structure orchestrate the spatial architecture of tumor immunityHaijia Tang, Youyang Shi, Qintao Ge, et al.
Disease Markers|July 21, 2022
Signature for Prostate Cancer Based on Autophagy-Related Genes and a Nomogram for Quantitative Risk StratificationChenghao Wen, Qintao Ge, Bangshun Dai, et al.
Prostate International|January 16, 2025
Insights from immunomics and metabolomics on the associations between prostatic diseases and coronavirus disease 2019Feixiang Yang, Peng Guo, Kun Wang, et al.
Frontiers in Immunology|June 26, 2025
Prognostic and immunological implications of cathepsin Z overexpression in prostate cancerJunyue Tao, Yiding Chen, Xiaokang Bian, et al.
Zhejiang Da Xue Xue Bao. Yi Xue Ban = Journal of Zhejiang University. Medical Sciences|June 7, 2023
Feasibility and safety of bipolar-plasmakinetic transurethral enucleation and resection of the prostate in day surgery modeZhihui Zou, Ligang Zhang, Keke Cai, et al.
Medcomm|May 21, 2026
Regulation of Immune Checkpoints: From Molecular Mechanisms to Clinical TherapiesQintao Ge, Liu Yu, Jiahe Lu, et al.
Molecular Therapy Oncolytics|March 5, 2021
Tumor immune microenvironment-based classifications of bladder cancer for enhancing the response rate of immunotherapyJialin Meng, Xiaofan Lu, Yujie Zhou, et al.
Translational Oncology|June 26, 2024
Integrated analysis of histone modification features in clear cell renal cancer for risk stratification and therapeutic predictionWenming Ma, Qintao Ge, Yu Guan, et al.
Frontiers in Pharmacology|October 6, 2022
EPM2A acts as a protective factor in prostate cancer, evidence from a real-world patient cohortQintao Ge, Jiawei Li, Junyue Tao, et al.
Pageof 4